Brief: Auris Medical Launches Development Of Drug-Free Nasal Spray For Protection Against Airborne Pathogens And Allergens
Sept 8 (Reuters) - Auris Medical Holding Ltd EARS.O :
* AURIS MEDICAL LAUNCHES DEVELOPMENT OF DRUG-FREE NASAL
SPRAY FOR
PROTECTION AGAINST AIRBORNE PATHOGENS AND ALLERGENS
* AURIS MEDICAL HOLDING LTD - SET UP A NEW SUBSIDIARY,
ALTAMIRA
MEDICA LTD. BASED IN ZUG, SWITZERLAND
Source text for Eikon: ID:nGNX5vLnVS
Further company coverage: EARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering